Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs.

Fadini GP, Dassie F, Albiero M, Boscaro E, Albano I, Martini C, de Kreutzenberg SV, Agostini C, Avogaro A, Vettor R, Maffei P.

J Clin Endocrinol Metab. 2014 Dec;99(12):E2549-56. doi: 10.1210/jc.2014-2275.

PMID:
25144634
2.

Circulating endothelial progenitor cells in acromegaly.

Bellastella G, Maiorino MI, Pivonello R, Grasso LF, Galdiero M, Sinisi AA, Colao A, Giugliano D, Esposito K.

J Endocrinol Invest. 2013 Nov;36(10):825-30. doi: 10.3275/9020. Epub 2013 Jun 26.

PMID:
23801271
3.

Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus.

Yue WS, Lau KK, Siu CW, Wang M, Yan GH, Yiu KH, Tse HF.

Cardiovasc Diabetol. 2011 Dec 20;10:113. doi: 10.1186/1475-2840-10-113.

4.

Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly.

Niculescu D, Purice M, Coculescu M.

Pituitary. 2013 Jun;16(2):168-74. doi: 10.1007/s11102-012-0396-6.

PMID:
22562529
5.

Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA.

De Marinis L, Bianchi A, Fusco A, Cimino V, Mormando M, Tilaro L, Mazziotti G, Pontecorvi A, Giustina A.

Pituitary. 2007;10(3):227-32.

PMID:
17484056
6.

Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly.

Bianchi A, Giustina A, Cimino V, Pola R, Angelini F, Pontecorvi A, De Marinis L.

J Clin Endocrinol Metab. 2009 Jun;94(6):2015-22. doi: 10.1210/jc.2008-1337. Epub 2009 Mar 31.

PMID:
19336510
7.

Serum prostate-specific antigen concentration is increased in acromegalic women.

Manetti L, Lupi I, Genovesi M, Morselli L, Grasso L, Nencetti C, Gasperi M, Bogazzi F, Bartalena L, Martino E.

J Endocrinol Invest. 2004 Jul-Aug;27(7):643-7.

PMID:
15505987
8.

Effects of medical therapies for acromegaly on glucose metabolism.

Urbani C, Sardella C, Calevro A, Rossi G, Scattina I, Lombardi M, Lupi I, Manetti L, Martino E, Bogazzi F.

Eur J Endocrinol. 2013 Jun 7;169(1):99-108. doi: 10.1530/EJE-13-0032. Print 2013 Jul.

9.

Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling.

Calò LA, Facco M, Davis PA, Pagnin E, Maso LD, Puato M, Caielli P, Agostini C, Pessina AC.

Hypertens Res. 2011 Sep;34(9):1017-22. doi: 10.1038/hr.2011.72. Epub 2011 Jun 9.

PMID:
21654754
10.

Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.

Petrossians P, Borges-Martins L, Espinoza C, Daly A, Betea D, Valdes-Socin H, Stevenaert A, Chanson P, Beckers A.

Eur J Endocrinol. 2005 Jan;152(1):61-6.

11.

Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.

Tolis G, Angelopoulos NG, Katounda E, Rombopoulos G, Kaltzidou V, Kaltsas D, Protonotariou A, Lytras A.

Neuroendocrinology. 2006;83(3-4):249-57. Epub 2006 Oct 13. Review.

PMID:
17047390
12.

Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.

Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G, Lodrini A, Lombardi G, Cozzi R.

J Clin Endocrinol Metab. 2006 Jan;91(1):85-92. Epub 2005 Nov 1.

PMID:
16263832
13.

Reduced circulating endothelial progenitor cell number in healthy young adult hyperinsulinemic men.

Dei Cas A, Spigoni V, Ardigò D, Pedrazzi G, Franzini L, Derlindati E, Urbani S, Monti L, Gnudi L, Zavaroni I.

Nutr Metab Cardiovasc Dis. 2011 Jul;21(7):512-7. doi: 10.1016/j.numecd.2009.11.011. Epub 2010 Mar 15.

PMID:
20227256
14.

Effects of two different somatostatin analogs on glucose tolerance in acromegaly.

Ronchi C, Epaminonda P, Cappiello V, Beck-Peccoz P, Arosio M.

J Endocrinol Invest. 2002 Jun;25(6):502-7.

PMID:
12109620
15.

Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance.

Colao A, Pivonello R, Auriemma RS, De Martino MC, Bidlingmaier M, Briganti F, Tortora F, Burman P, Kourides IA, Strasburger CJ, Lombardi G.

Eur J Endocrinol. 2006 Mar;154(3):467-77.

16.

Acromegaly.

Scacchi M, Cavagnini F.

Pituitary. 2006;9(4):297-303. Review.

PMID:
17077948
17.

Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment.

Baldelli R, Battista C, Leonetti F, Ghiggi MR, Ribaudo MC, Paoloni A, D'Amico E, Ferretti E, Baratta R, Liuzzi A, Trischitta V, Tamburrano G.

Clin Endocrinol (Oxf). 2003 Oct;59(4):492-9.

PMID:
14510913
18.

Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study.

Colao A, Auriemma RS, Galdiero M, Lombardi G, Pivonello R.

J Clin Endocrinol Metab. 2009 Oct;94(10):3746-56. doi: 10.1210/jc.2009-0941. Epub 2009 Jul 21.

PMID:
19622615
19.

Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men.

Esposito K, Ciotola M, Maiorino MI, Giugliano F, Autorino R, De Sio M, Jannini E, Lenzi A, Giugliano D.

J Sex Med. 2009 Jan;6(1):107-14. doi: 10.1111/j.1743-6109.2008.01042.x.

PMID:
19170841
20.

Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes.

Yiu YF, Chan YH, Yiu KH, Siu CW, Li SW, Wong LY, Lee SW, Tam S, Wong EW, Cheung BM, Tse HF.

J Clin Endocrinol Metab. 2011 May;96(5):E830-5. doi: 10.1210/jc.2010-2212. Epub 2011 Feb 16.

PMID:
21325459
Items per page

Supplemental Content

Write to the Help Desk